KEVIN MCGUINESS PLLC for TEVA PHARMACEUTICALS USA INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 369, the Preserve Access to Affordable Generics Act H.R. 1427, the Promoting Innovation and Access to Life-Saving Medicine Act
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Labor Issues/Antitrust/Workplace LBR
S. 639, the Preserve Access to Affordable Generics Act
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Copyright/Patent/Trademark CPT
S. 515, the Patent Reform Act of 2009
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.